Key facts
- · Type: New offering first sale 2026-01-13 · Amount sold: $3.30M · Total offering: $3.30M · SEC filing
- · Type: New offering first sale 2024-03-15 · Amount sold: $61.55M · Total offering: $61.55M · SEC filing
- · Type: Filing · SEC filing
Is BiomX Inc. a real, registered company?
BiomX Inc. is a registered filer with the SEC (CIK 1739174) and has filed since 2023-03-03. 3 filings are on record, the latest on 2026-01-20.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
How much has BiomX Inc. raised?
Its new offerings report $64.85M sold across 2 offerings, as its own filings state.
Run the free check on BiomX Inc. →
NESS ZIONA, ISRAEL
Pharmaceuticals
3
$64.85M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-01-20 | New offering first sale 2026-01-13 | $3.30M | $3.30M | SEC filing |
| 2024-04-01 | New offering first sale 2024-03-15 | $61.55M | $61.55M | SEC filing |
| 2023-03-03 | Filing | — | — | SEC filing |
Keep reading
More on BiomX Inc. and the records around it.
BiomX Inc. elsewhere on the record
- Leadership changes Oct 2026
- 5%+ stake filings Oct 2026
- Acquisition Apr 2026
- Form D filing Jan 2026
- Who owns it
Companies that share a holder
- Rodney Hodges also filed stake reports on 1 other company: PolyPid Ltd. (Aug 2026)
- Deerfield Private Design Fund V, L.P. also filed stake reports on 19 other companies: Climb Bio, Inc. (Oct 2026), Cogent Biosciences, Inc. (Aug 2026), Enhabit, Inc. (Aug 2026)
- Orin Hirschman also filed stake reports on 46 other companies: ASPEN AEROGELS, INC. (Oct 2026), Bionano Genomics, Inc. (Oct 2026), FENNEC PHARMACEUTICALS INC. (Oct 2026)
Watch BiomX Inc.
Get an email when BiomX Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with BiomX Inc.?
Who to contact
- Jonathan Solomon — Chief Executive Officer
- Marina Wolfson — Chief Financial Officer
- Merav Bassan — Chief Development Officer
- Susan Blum — Director
- Jesse Goodman — Director
- Russell Greig — Director
- Jonathan Leff — Director
- Gregory Merril — Director
- Alan Moses — Director
- Eddie Williams — Director
- Round: Form D filed 2026-01-20
- Amount sold: $3.30M
- Industry: Pharmaceuticals
- Based: NESS ZIONA, ISRAEL
People listed
- Jonathan Solomon — Chief Executive Officer
- Marina Wolfson — Chief Financial Officer
- Merav Bassan — Chief Development Officer
- Susan Blum — Director
- Jesse Goodman — Director
- Russell Greig — Director
- Jonathan Leff — Director
- Gregory Merril — Director
- Alan Moses — Director
- Eddie Williams — Director
- Filing: Form D filed 2026-01-20
- Amount sold: $3.30M
- Industry group: Pharmaceuticals
- Based: NESS ZIONA, ISRAEL
- Entity type: Corporation
We'll show it in your MentionFox inbox when BiomX Inc. raises, hires or launches. No email unless you switch it on.
Watch BiomX Inc. →Want the whole picture on BiomX Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on BiomX Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on BiomX Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from BiomX Inc.'s own filings with the SEC. The people those filings name are on the team page.